348 related articles for article (PubMed ID: 24953060)
1. Advances in the management of colorectal cancer: from biology to treatment.
Ahmed S; Johnson K; Ahmed O; Iqbal N
Int J Colorectal Dis; 2014 Sep; 29(9):1031-42. PubMed ID: 24953060
[TBL] [Abstract][Full Text] [Related]
2. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
3. [Colorectal cancer - personalized, stage-adjusted tumour therapy].
Pohl M; Schmiegel W
Dtsch Med Wochenschr; 2013 Sep; 138(36):1790-5. PubMed ID: 24002881
[TBL] [Abstract][Full Text] [Related]
4. Palliative care and end-stage colorectal cancer management: the surgeon meets the oncologist.
Costi R; Leonardi F; Zanoni D; Violi V; Roncoroni L
World J Gastroenterol; 2014 Jun; 20(24):7602-21. PubMed ID: 24976699
[TBL] [Abstract][Full Text] [Related]
5. From tumour heterogeneity to advances in precision treatment of colorectal cancer.
Punt CJ; Koopman M; Vermeulen L
Nat Rev Clin Oncol; 2017 Apr; 14(4):235-246. PubMed ID: 27922044
[TBL] [Abstract][Full Text] [Related]
6. GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.
Lin WR; Chiang JM; Liang KH; Lim SN; Lai MW; Tsou YK; Hsieh TY; Hsu CK; Yeh CT
Medicine (Baltimore); 2016 Apr; 95(17):e3487. PubMed ID: 27124048
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, disease progression, and economic burden of colorectal cancer.
Benson AB
J Manag Care Pharm; 2007 Aug; 13(6 Suppl C):S5-18. PubMed ID: 17713990
[TBL] [Abstract][Full Text] [Related]
8. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
9. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
Rossi S; Basso M; Strippoli A; Schinzari G; D'Argento E; Larocca M; Cassano A; Barone C
Clin Colorectal Cancer; 2017 Dec; 16(4):264-274. PubMed ID: 28412137
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Chemotherapy With or Without Biologics Including Antiangiogenics and Monoclonal Antibodies Targeting EGFR and EpCAM in Colorectal Cancer: A Systematic Review and Meta-analysis.
Serrano PE; Carter DN; Li C; Valencia M; Ruo L; Parpia S; Simunovic M; Levine O
J Surg Res; 2019 Jul; 239():14-21. PubMed ID: 30782542
[TBL] [Abstract][Full Text] [Related]
11. Curable metastatic colorectal cancer.
Eadens MJ; Grothey A
Curr Oncol Rep; 2011 Jun; 13(3):168-76. PubMed ID: 21298372
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?
Khan K; Wale A; Brown G; Chau I
World J Gastroenterol; 2014 Sep; 20(35):12391-406. PubMed ID: 25253940
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
Ihnát P; Vávra P; Zonča P
World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes after surgical resection in patients with stage IV colorectal cancer: a retrospective study of 129 patients at a single institution.
Sudo M; Furuya S; Shimizu H; Nakata Y; Iino H; Shiraishi K; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Inoue S; Kono H; Ichikawa D
World J Surg Oncol; 2019 Mar; 17(1):56. PubMed ID: 30904026
[TBL] [Abstract][Full Text] [Related]
15. The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy.
Min BH; Bae JM; Lee EJ; Yu HS; Kim YH; Chang DK; Kim HC; Park CK; Lee SH; Kim KM; Kang GH
BMC Cancer; 2011 Aug; 11():344. PubMed ID: 21827707
[TBL] [Abstract][Full Text] [Related]
16. The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer.
Chu-Yuan H; Jing P; Yi-Sheng W; He-Ping P; Hui Y; Chu-Xiong Z; Guo-Jian L; Guo-Qiang W
BMC Cancer; 2013 Apr; 13():177. PubMed ID: 23551939
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary nodules and metastases in colorectal cancer.
Nordholm-Carstensen A
Dan Med J; 2016 Jan; 63(1):B5190. PubMed ID: 26726908
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
19. SEOM clinical guidelines for the treatment of advanced colorectal cancer 2013.
Casado-Saenz E; Feliu J; Gomez-España MA; Sanchez-Gastaldo A; Garcia-Carbonero R;
Clin Transl Oncol; 2013 Dec; 15(12):996-1003. PubMed ID: 23896865
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment.
Chan KM; Chiang JM; Lee CF; Yu MC; Lee WC; Chen JS; Wang JY
World J Surg Oncol; 2011 Dec; 9():174. PubMed ID: 22208884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
